These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 24998140

  • 21. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
    Abouhashem NS, Ibrahim DA, Mohamed AM.
    Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y, Zhong L, Duan D, Li T.
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [Abstract] [Full Text] [Related]

  • 24. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N, Kawano S, Yasuda K, Hashiguchi Y, Sakamoto T, Matsubara R, Goto Y, Jinno T, Maruse Y, Morioka M, Hattori T, Tanaka S, Tanaka H, Kiyoshima T, Nakamura S.
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [Abstract] [Full Text] [Related]

  • 25. SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation.
    Li W, Zhu D, Qin S.
    J Exp Clin Cancer Res; 2018 Jul 13; 37(1):148. PubMed ID: 30001742
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
    Min A, Xiong H, Wang W, Hu X, Wang C, Mao T, Yang L, Huang D, Xia K, Su T.
    J Oral Pathol Med; 2020 Nov 13; 49(10):1019-1029. PubMed ID: 32740991
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
    Perier A, Fregni G, Wittnebel S, Gad S, Allard M, Gervois N, Escudier B, Azzarone B, Caignard A.
    Oncogene; 2011 Jun 09; 30(23):2622-32. PubMed ID: 21258414
    [Abstract] [Full Text] [Related]

  • 32. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H, Honggang D, Qian W.
    Biochem Biophys Res Commun; 2018 Dec 09; 507(1-4):83-90. PubMed ID: 30454901
    [Abstract] [Full Text] [Related]

  • 33. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 34. TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.
    Shang D, Liu Y, Yang P, Chen Y, Tian Y.
    Urology; 2012 Apr 16; 79(4):966.e1-7. PubMed ID: 22341602
    [Abstract] [Full Text] [Related]

  • 35. Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells.
    Chen SF, Lin CY, Chang YC, Li JW, Fu E, Chang FN, Lin YL, Nieh S.
    J Oral Pathol Med; 2009 Oct 16; 38(9):722-30. PubMed ID: 19473443
    [Abstract] [Full Text] [Related]

  • 36. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM, Chi XH, Bo ZQ, Huang XF, Zhang J.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31439759
    [Abstract] [Full Text] [Related]

  • 37. Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway.
    Lee AY, Fan CC, Chen YA, Cheng CW, Sung YJ, Hsu CP, Kao TY.
    Integr Cancer Ther; 2015 Sep 30; 14(5):484-90. PubMed ID: 26036622
    [Abstract] [Full Text] [Related]

  • 38. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y, He MY, Zhu LF, Yang CC, Zhou ML, Wang Q, Zhang W, Zheng YY, Wang DM, Xu ZQ, Wu YN, Liu LK.
    J Exp Clin Cancer Res; 2016 Jan 15; 35():12. PubMed ID: 26769084
    [Abstract] [Full Text] [Related]

  • 39. CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Ling Z, Yang X, Chen X, Xia J, Cheng B, Tao X.
    J Oral Pathol Med; 2019 Jul 15; 48(6):477-482. PubMed ID: 31077446
    [Abstract] [Full Text] [Related]

  • 40. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE, Horta MC.
    J Appl Oral Sci; 2015 Jul 15; 23(2):169-78. PubMed ID: 26018309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.